tiprankstipranks
Trending News
More News >
Helix Biopharma Corp. (TSE:HBP)
:HBP
Canadian Market

Helix BioPharma (HBP) Technical Analysis

Compare
25 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
1Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Helix Biopharma Corp.’s (HBP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Helix Biopharma Corp. is a Sell.
Helix Biopharma Corp.’s (HBP) 20-Day exponential moving average is 0.93, while Helix Biopharma Corp.’s (HBP) share price is C$0.93, making it a Buy.
Helix Biopharma Corp.’s (HBP) 50-Day exponential moving average is 0.91, while Helix Biopharma Corp.’s (HBP) share price is C$0.93, making it a Buy.

Helix BioPharma (HBP) Pivot Points

Jul 04, 2025, 06:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.92
0.92
0.94
0.94
0.96
0.96
0.98
Fibonacci
0.92
0.93
0.94
0.94
0.95
0.96
0.96
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Helix BioPharma (HBP) Moving Averages

Jul 04, 2025, 06:00 AM
Period
Simple
Exponential
MA5
0.93Sell
0.93Sell
MA10
0.92Buy
0.93Buy
MA20
0.92Buy
0.93Buy
MA50
0.92Buy
0.91Buy
MA100
0.89Buy
0.91Buy
MA200
0.93Buy
0.96Sell
Helix Biopharma Corp.’s (HBP) 10-Day exponential moving average is 0.93, while Helix Biopharma Corp.’s (HBP) share price is C$0.93, making it a Buy.
Helix Biopharma Corp.’s (HBP) 100-Day exponential moving average is 0.91, while Helix Biopharma Corp.’s (HBP) share price is C$0.93, making it a Buy.
Helix Biopharma Corp.’s (HBP) stock price is C$0.93 and Helix Biopharma Corp.’s (HBP) 50-day simple moving average is 0.92, creating a Buy signal.
Helix Biopharma Corp.’s (HBP) stock price is C$0.93 and Helix Biopharma Corp.’s (HBP) 100-day simple moving average is 0.89, creating a Buy signal.
Helix Biopharma Corp.’s (HBP) stock price is C$0.93 and Helix Biopharma Corp.’s (HBP) 200-day simple moving average is 0.93, creating a Buy signal.

Helix BioPharma (HBP) Technical Indicators

Jul 04, 2025, 06:00 AM
Name
Value
Implied Action
RSI (14)
53.18
Neutral
STOCH (9,6)
93.94
Sell
STOCHRSI (14)
93.94
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
19.52
Buy
Williams %R
-18.18
Sell
CCI (14)
-176.05
Buy
ATR (14)
0.02
-
Ultimate Oscillator
81.04
Buy
ROC
0.00
Buy
Helix Biopharma Corp.’s (HBP) Relative Strength Index (RSI) is 53.18, creating a Neutral signal.
Helix Biopharma Corp.’s (HBP) Trend Strength Indicator (ADX) is 19.52, creating a Buy signal.
Helix Biopharma Corp.’s (HBP) Commodity Channel Index (CCI) is -176.05, creating a Buy signal.

FAQ

Is HBP a Buy, Hold, or Sell?
Based on HBP’s technical indicators, HBP is a Buy.
    What is HBP’s RSI (14)?
    HBP’s RSI (14) is 53.18, which suggests HBP is a Neutral.
      What is HBP’s MACD?
      HBP’s MACD is <0.01, which suggests HBP is a Sell.
        What is HBP’s 5-day moving average?
        HBP’s 5-day moving average is 0.93, which suggests HBP is a Sell.
          What is HBP’s 20-day moving average?
          HBP 20-day moving average is 0.92, which suggests HBP is a Buy.
            What is HBP’s 50-day moving average?
            HBP’s 50-day moving average is 0.92, which suggests HBP is a Buy.
              What is HBP’s 200-day moving average?
              HBP’s 200-day moving average is 0.93, which suggests HBP is a Buy.
                What is HBP’s Williams % R (14)?
                HBP’s Williams % R (14) is -18.18, which suggests HBP is a Sell.
                  What is HBP’s CCI (14)?
                  HBP’s CCI (14) is -176.05, which suggests HBP is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis